Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models
  2. Schmid, Sebastian; Russell, Zachary R; Shimura Yamashita,Alex; West, Madeline E; Parrish, Abigail G; Walker, Julia; Rudoy, Dmytro; Yan, James Z; Quist, David C; Gessesse, Betemariyam N; Alvinez, Neriah; Hill, Kimberly D; Anderson,Larry; Cimino, Patrick J; Kumasaka, Debra K; Parchment,Ralph; Holland, Eric C; Szulzewsky, Frank
  3. Cell Reports. 2024, Oct 03; 43(10): 114829.
  1. 2.   Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
  2. Fermaintt, Charles S.; Peramuna, Thilini; Cai, Shengxin; Takahashi-Ruiz, Leila; Essif, Jacob Nathaniel; Grant, Corena V.; O'Keefe,Barry; Mooberry, Susan L.; Cichewicz, Robert H.; Risinger, April L.
  3. Cancers. 2021, JUN; 13(11):
  1. 3.   Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
  2. Hong, Jaewoo; Jhun, Hyunjhung; Choi, Yeo-Ok; Taitt, Afeisha S.; Bae, Suyoung; Lee, Youngmin; Song, Chang-seon; Yeom, Su Cheong; Kim, Soohyun
  3. Immune Network. 2021, Feb 19; 21(1):
  1. 4.   Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
  2. Flaherty, Keith T; Gray, Robert J; Chen, Alice P; Li, Shuli; McShane, Lisa M; Patton, David; Hamilton, Stanley R; Williams,Mickey; Iafrate, A John; Sklar, Jeffrey; Mitchell, Edith P; Harris, Lyndsay N; Takebe, Naoko; Sims,David; Coffey,Brent; Fu,Tony; Routbort, Mark; Zwiebel, James A; Rubinstein, Larry V; Little, Richard F; Arteaga, Carlos L; Comis, Robert; Abrams, Jeffrey S; O'Dwyer, Peter J; Conley, Barbara A
  3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020, NOV 20; 38(33): pii: JCO1903010.
  1. 5.   Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model
  2. Kiyuna, Tasuku; Murakami, Takashi; Tome, Yasunori; Igarashi, Kentaro; Kawaguchi, Kei; Miyake, Kentaro; Miyake, Masuyo; Li, Yunfeng; Nelson, Scott D; Dry, Sarah M; Singh, Arun S; Russell, Tara A; Singh, Shree Ram; Kanaya, Fuminori; Eilber, Fritz C; Hoffman, Robert M
  3. Tissue & Cell. 2018, Aug; 53: 30-36.
  1. 6.   Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain
  2. Qian, Y. Z.; Hua, E.; Bisht, K.; Woditschka, S.; Skordos, K. W.; Liewehr, D. J.; Steinberg, S. M.; Brogi, E.; Akram, M. M.; Killian, J. K.; Edelman, D. C.; Pineda, M.; Scurci, S.; Degenhardt, Y. Y.; Laquerre, S.; Lampkin, T. A.; Meltzer, P. S.; Camphausen, K.; Steeg, P. S.; Palmieri, D.
  3. Clinical & Experimental Metastasis. 2011, Dec; 28(8): 899-908.
  1. 7.   Targeting KRAS Directly
  2. McCormick, Frank
  3. ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2. 2018; 2 : 81-90.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel